Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.45
-0.05 (-0.53%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Avid Bioservices Revenue
In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M. Revenue in the quarter ending April 30, 2024 was $42.98M with 7.98% year-over-year growth.
Revenue (ttm)
$139.91M
Revenue Growth
-6.27%
P/S Ratio
4.29
Revenue / Employee
$377,119
Employees
371
Market Cap
600.84M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 139.91M | -9.36M | -6.27% |
Apr 30, 2023 | 149.27M | 29.67M | 24.81% |
Apr 30, 2022 | 119.60M | 23.73M | 24.75% |
Apr 30, 2021 | 95.87M | 36.17M | 60.58% |
Apr 30, 2020 | 59.70M | 6.10M | 11.38% |
Apr 30, 2019 | 53.60M | -18.00K | -0.03% |
Apr 30, 2018 | 53.62M | -4.01M | -6.96% |
Apr 30, 2017 | 57.63M | 13.27M | 29.92% |
Apr 30, 2016 | 44.36M | 17.58M | 65.63% |
Apr 30, 2015 | 26.78M | 4.38M | 19.55% |
Apr 30, 2014 | 22.40M | 718.00K | 3.31% |
Apr 30, 2013 | 21.68M | 6.45M | 42.34% |
Apr 30, 2012 | 15.23M | 1.74M | 12.90% |
Apr 30, 2011 | 13.49M | -14.45M | -51.72% |
Apr 30, 2010 | 27.94M | 9.79M | 53.95% |
Apr 30, 2009 | 18.15M | 12.06M | 197.90% |
Apr 30, 2008 | 6.09M | 2.39M | 64.32% |
Apr 30, 2007 | 3.71M | 515.00K | 16.13% |
Apr 30, 2006 | 3.19M | -1.77M | -35.61% |
Apr 30, 2005 | 4.96M | 1.65M | 49.64% |
Apr 30, 2004 | 3.31M | -607.00K | -15.48% |
Apr 30, 2003 | 3.92M | 155.00K | 4.12% |
Apr 30, 2002 | 3.77M | 2.79M | 284.68% |
Apr 30, 2001 | 979.00K | 929.00K | 1,858.00% |
Apr 30, 2000 | 50.00K | - | - |
Apr 30, 1999 | 0 | - | - |
Apr 30, 1998 | 0 | - | - |
Apr 30, 1997 | 0 | - | - |
Apr 30, 1996 | 3.14M | 3.14M | 42,429.06% |
Apr 30, 1995 | 7.39K | -61.98K | -89.34% |
Apr 30, 1994 | 69.37K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Emergent BioSolutions | 1.19B |
ZimVie | 350.20M |
Pharming Group | 280.83M |
Adaptive Biotechnologies | 174.50M |
Surmodics | 142.96M |
Allogene Therapeutics | 65.00K |
CDMO News
- 19 days ago - Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 - GlobeNewsWire
- 21 days ago - Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 - GlobeNewsWire
- 2 months ago - Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance - GlobeNewsWire
- 2 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO - PRNewsWire
- 2 months ago - Avid Bioservices to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 - GlobeNewsWire
- 4 months ago - Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q - GlobeNewsWire
- 4 months ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire